Literature DB >> 23756245

The role of CARMA1 in T cells.

Marly I Roche1, Ravisankar A Ramadas, Benjamin D Medoff.   

Abstract

Caspase recruitment domain-containing membrane-associated guanylate kinase protein-1 (CARMA1), a member of the membrane associated guanylate kinase (MAGUK) family of kinases, is essential for T lymphocyte activation and proliferation via T-cell receptor (TCR) mediated NF-κB activation. Recent studies suggest a broader role for CARMA1 regulating other T-cell functions as well as a role in non-TCR-mediated signaling pathways important for lymphocyte development and functions. In addition, CARMA1 has been shown to be an important component in the pathogenesis of several human diseases. Thus, comprehensively defining its mechanisms of action and regulation could reveal novel therapeutic targets for T-cell-mediated diseases and lymphoproliferative disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23756245      PMCID: PMC3690520          DOI: 10.1615/critrevimmunol.2013007056

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  158 in total

Review 1.  It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation.

Authors:  Lawrence P Kane; Joseph Lin; Arthur Weiss
Journal:  Trends Immunol       Date:  2002-08       Impact factor: 16.687

2.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Authors:  F A Harding; J G McArthur; J A Gross; D H Raulet; J P Allison
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

Review 3.  NF-κB signaling pathways regulated by CARMA family of scaffold proteins.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

Review 4.  Fine-tuning CD4+ central memory T cell heterogeneity by strength of stimulation.

Authors:  Vandana Kalia; Surojit Sarkar; Rafi Ahmed
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

5.  Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2.

Authors:  D D Yang; D Conze; A J Whitmarsh; T Barrett; R J Davis; M Rincón; R A Flavell
Journal:  Immunity       Date:  1998-10       Impact factor: 31.745

6.  JNK is required for effector T-cell function but not for T-cell activation.

Authors:  C Dong; D D Yang; C Tournier; A J Whitmarsh; J Xu; R J Davis; R A Flavell
Journal:  Nature       Date:  2000-05-04       Impact factor: 49.962

7.  Mature T cells depend on signaling through the IKK complex.

Authors:  Marc Schmidt-Supprian; Gilles Courtois; Jane Tian; Anthony J Coyle; Alain Israël; Klaus Rajewsky; Manolis Pasparakis
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

8.  Defective T cell differentiation in the absence of Jnk1.

Authors:  C Dong; D D Yang; M Wysk; A J Whitmarsh; R J Davis; R A Flavell
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

9.  Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation.

Authors:  Maria A Curotto de Lafaille; Nino Kutchukhidze; Shiqian Shen; Yi Ding; Herman Yee; Juan J Lafaille
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

10.  CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptor-induced NF-kappaB activation.

Authors:  Matthew J Tanner; Walter Hanel; Sarah L Gaffen; Xin Lin
Journal:  J Biol Chem       Date:  2007-04-11       Impact factor: 5.157

View more
  9 in total

1.  Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.

Authors:  Wenbin Wang; Xudong Chang; Wei Yao; Ning Wei; Na Huo; Yanhong Wang; Qiaolin Wei; Haijin Liu; Xinglong Wang; Shuxia Zhang; Zengqi Yang; Sa Xiao
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

2.  CARD11 blockade suppresses murine collagen-induced arthritis via inhibiting CARD11/Bcl10 assembly and T helper type 17 response.

Authors:  H Wang; J Zhao; H Zhang; Y Huang; S Wang; Q Tu; N Yang
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

Review 3.  Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells.

Authors:  Ling Wu; Qianru Wei; Joanna Brzostek; Nicholas R J Gascoigne
Journal:  Cell Mol Immunol       Date:  2020-05-25       Impact factor: 11.530

4.  T cell-NF-κB activation is required for tumor control in vivo.

Authors:  Sarah E Barnes; Ying Wang; Luqiu Chen; Luciana L Molinero; Thomas F Gajewski; Cesar Evaristo; Maria-Luisa Alegre
Journal:  J Immunother Cancer       Date:  2015-01-20       Impact factor: 13.751

5.  Cellular CARD11 Inhibits the Fusogenic Activity of Newcastle Disease Virus via CBM Signalosome-Mediated Furin Reduction in Chicken Fibroblasts.

Authors:  Wenbin Wang; Qiaolin Wei; Qiqi Hao; Yajie Zhang; Yongshan Li; Youkun Bi; Zhongyuan Jin; Haijin Liu; Xuelan Liu; Zengqi Yang; Sa Xiao
Journal:  Front Microbiol       Date:  2021-02-02       Impact factor: 5.640

Review 6.  The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.

Authors:  Stuart E Turvey; Anne Durandy; Alain Fischer; Shan-Yu Fung; Raif S Geha; Andreas Gewies; Thomas Giese; Johann Greil; Bärbel Keller; Margaret L McKinnon; Bénédicte Neven; Jacob Rozmus; Jürgen Ruland; Andrew L Snow; Polina Stepensky; Klaus Warnatz
Journal:  J Allergy Clin Immunol       Date:  2014-08       Impact factor: 10.793

7.  AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation.

Authors:  Gisela Schimmack; Andrea C Eitelhuber; Michelle Vincendeau; Katrin Demski; Hisaaki Shinohara; Tomohiro Kurosaki; Daniel Krappmann
Journal:  Cell Commun Signal       Date:  2014-07-22       Impact factor: 5.712

Review 8.  "Immune TOR-opathies," a Novel Disease Entity in Clinical Immunology.

Authors:  Sophie Jung; Laura Gámez-Díaz; Michele Proietti; Bodo Grimbacher
Journal:  Front Immunol       Date:  2018-05-09       Impact factor: 7.561

Review 9.  The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.

Authors:  Henry Y Lu; Bradly M Bauman; Swadhinya Arjunaraja; Batsukh Dorjbal; Joshua D Milner; Andrew L Snow; Stuart E Turvey
Journal:  Front Immunol       Date:  2018-09-19       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.